A systematic-review protocol asked whether alpha-2 agonist evidence applied to brain-injured ventilated patients. It did not report completed comparative results against benzodiazepines.
The authors proposed reviewing randomized and observational studies of adult neurocritical nonprocedural sedation. Primary outcomes concerned arterial pressure, intracranial pressure, and cerebral perfusion pressure.
Other planned outcomes included ventilation, mortality, ICU stay, delirium, adverse events, and sedation quality. Subgroups would consider diagnosis, dose, adjuncts, and study design.
A sedative that changes systemic pressure may have different implications when intracranial pressure and cerebral perfusion are important. General-ICU outcomes cannot automatically settle those questions.
This supplied paper describes planned searches, pooling criteria, and evidence grading. It contains no completed pooled estimate showing that clonidine or dexmedetomidine improved neurocritical outcomes. The protocol helps identify endpoints a comparison should measure, but cannot prove that replacing a benzodiazepine would have protected the brain or shortened ventilation in a particular patient.
Original analysis of the supplied journal article, identified as PMC5016878.